Clin2
NCT06426836Possibly a fitRecruiting

Better antibiotic dosing for children on ECMO

PharmacokineticsAmoxicillin-clavulanatePiperacillin-tazobactamMeropenemCefazolinTeicoplaninVancomycinCiprofloxacin

Treatments studied

Amoxicillin-clavulanatePiperacillin-tazobactamMeropenemCefazolinVancomycinCiprofloxacinAmikacin

Part of Infections clinical trials.

This trial studies how to give the right dose of common antibiotics to children on ECMO (a heart-lung bypass machine). The goal is to help doctors choose the best dose to fight infections while keeping the child safe.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
300 people
Ages
Up to 15 years
Study type
Interventional

Who can take part

  • Your child must be in the pediatric or cardiac intensive care unit (ICU).
  • Your child must weigh at least 1.8 kg and be under 15 years old.
  • Your child must be on ECMO (a machine that helps the heart and lungs).
  • Your child must be receiving one of the listed antibiotics through an IV line.
  • Doctors must be able to draw blood samples from a separate line (not the one giving the antibiotic).
  • There must be no known allergy to certain antibiotics like penicillin or ciprofloxacin.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT02456974Recruiting
Testing how antibiotics are dosed in children’s intensive care

This study looks at whether giving common antibiotics in certain dose schedules (either through a drip over time or continuously) is done in a way that fits pediatric intensive care needs. It may help improve antibiotic treatment for children who are very sick and need antibiotics.

Ghent
NCT06929702Not yet recruiting· Phase 4
Precision dosing of antibiotics for critically ill children

This trial tests a personalized dosing approach for certain antibiotics (amoxicillin-clavulanic acid, piperacillin-tazobactam, and meropenem) in hospitalized children with serious infections. The goal is to adjust the dose based on blood tests to make sure each child gets the right amount of medicine.

Ghent
NCT06026852Not yet recruiting
Using a tool to personalize antibiotic dosing in the ICU

This study tests a computer tool that helps doctors give the right dose of strong antibiotics to ICU patients. It is for adults who have recently started one of two specific antibiotics.

Ghent
NCT06602557Recruiting· Phase 2
Inhaled antibiotic for lung infection during ECMO support

This trial tests whether adding an inhaled antibiotic (amikacin) to standard IV antibiotics can better treat a serious lung infection (pneumonia caused by Gram-negative bacteria) in patients on a heart-lung machine (ECMO) and a breathing tube. If you or your loved one is on ECMO and has this type of pneumonia, this study may offer a new treatment approach.

Paris
NCT06338345Not yet recruiting
Study of antibiotics in people on heart-lung machine

This study looks at how well certain strong antibiotics (Piperacillin-Tazobactam, Cefepime, or Meropenem) work in the body when a person is on a heart-lung machine called VA-ECMO. It aims to find the best dose for these antibiotics in this situation.

Clermont-Ferrand
NCT07484633Not yet recruiting· Phase 4
Testing extended vs. standard antibiotic infusions in children with sepsis

This trial compares giving a long, continuous infusion versus standard short infusions of certain antibiotics (beta-lactams) to children with sepsis in intensive care. The goal is to find which method works better and is safer.

Budapest

Hear when a new Amoxicillin-clavulanate trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.